Cookies show us what works. Privacy
Cookies show us what works. Privacy
22 funds hold it · Insiders net buying
Net buying: insiders sold $16K and bought $263K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Nov 10, 2026
Period ending
Oct 3, 2026
Earnings per share
$0.15 expected
Estimates as of Nov 13, 2026
EPS expected
$0.12 to $0.19
Revenue expected
13 analysts
Last 30 days
Analysts cutting estimates
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Oct 3, 2026Reported Nov 10, 2026 | $0.16est. $0.15 | +5.70%beat | $1.18BSEC filing | +0.9%from $1.17B |
| Jul 4, 2026Reported Aug 12, 2026 | Not on file | No estimate | $1.19BSEC filing | +1.1%from $1.18B |
| Apr 4, 2026Reported May 13, 2026 | $0.05est. $0.02 | +$0.03beat | $1.17BSEC filing | +3.6%from $1.13B |
| Dec 31, 2025Reported Mar 4, 2026 | $0.19est. $0.21 | -10.59%miss | $4.69B · FYSEC filing | No year-ago quarter |
| Sep 27, 2025Reported Nov 4, 2025 | $0.21est. $0.19 | +11.48%beat | $1.17BSEC filing | +5.4%from $1.11B |
| Jun 28, 2025Reported Aug 5, 2025 | $0.23est. $0.17 | +35.29%beat | $1.18BSEC filing | +4.5%from $1.13B |
| Mar 29, 2025Reported May 6, 2025 | $0.13est. $0.07 | +$0.06beat | $1.13BSEC filing | +8.5%from $1.04B |
| Dec 31, 2024Reported Feb 25, 2025 | $0.15est. $0.17 | -10.29%miss | $4.37B · FYSEC filing | No year-ago quarter |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
This company is not yet profitable.
Valuation
Quality
Growth
This stock is trending upward.
Trend
Constructive
60 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace